SCHEMBL7387266

SCHEMBL7387266

Cc1ccc(S(=O)(=O)Nc2ccc(-c3cc4[nH]c(=O)[nH]c4nc3C)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
PDE3B Q13370 3/20 0.57
PDE3A Q14432 3/20 0.57
PTPN2 P17706 2/20 0.55
PTPN1 P18031 2/20 0.55
PTPN5 P54829 2/20 0.55
HSPD1 P10809 1/20 0.55
HSPE1 P61604 1/20 0.55
KIT P10721 3/20 0.47
ALDH1A1 P00352 5/20 0.47
PKM P14618 2/20 0.47
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 5/20 0.47
MAPT P10636 4/20 0.47
GAA P10253 3/20 0.47
HPGD P15428 2/20 0.47
GLA P06280 1/20 0.47
RORC P51449 1/20 0.47
ALOX12 P18054 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7377905 0.84 PDE3B (0.64) MEN1KMT2APDE3BPDE3AKIT
SCHEMBL7385190 0.81 PDE3B (0.58) MEN1KMT2APDE3BPDE3APTPN1
SCHEMBL7383419 0.79 PDE3B (0.70) PDE3BPDE3A
SCHEMBL7378034 0.78 PDE3B (0.55) PDE3BPDE3APTPN5KITALDH1A1
SCHEMBL7380456 0.77 MEN1 (0.53) MEN1KMT2APDE3BPDE3AALDH1A1
SCHEMBL7382397 0.76 PDE3B (0.53) PDE3BPDE3AKITKDM4EHPGD
SCHEMBL7382885 0.75 PDE3B (0.72) PDE3BPDE3A
SCHEMBL7386282 0.75 PDE3B (0.72) PDE3BPDE3A
SCHEMBL22425029 0.75 KMT2A (0.84) MEN1KMT2AALDH1A1PKMMAPK1
SCHEMBL7384334 0.75 PDE3B (0.64) MEN1KMT2APDE3BPDE3AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4963561-A Phosphodiesterase inhibitors STERLING DRUG INC. (US) 1990-10-16 US claimed
US-5010086-A Enzyme inhibitor for treating congestive heart failure or hypertension in mammals STERLING DRUG INC. (US) 1991-04-23 US disclosed